FindTrial
Sign In

Serum Angiogenic Factors Changes in Patients with Acute Pain and Subacute Pain

AXL participation in neurological pain mechanism and intervention test research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061775
Enrollment
Unknown
Registered
2022-07-02
Start date
2016-10-11
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain

Interventions

Neuropathic pain patients group:none
healthy participants group:none

Sponsors

Tianjin Union Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with neuropathy; 2. The patients with reading and writing ability and completing the self-assessment; 3. No severe heart, lung, liver, kidney, brain, other diseases, and mental illness; 4. Agree to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe hearing impairment, cognitive impairment, and other reasons lead to patients can not cooperative with the scale evaluation; 2. Patients and their families refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
visual analogue scale of pain;osteopontin;thrombospondin-2;soluble platelet endothelial cell adhesion molecule-1 ; soluble urokinase-type plasminogen activator receptor;soluble epidermal growth factor receptors;soluble human epidermal growth factor receptor 2 ;soluble human epidermal growth factor receptor 3;soluble interleukin-6 receptor a;soluble AXL;tenascin C;soluble neuropilin-1;—

Countries

China

Contacts

Public ContactJun Zhang

Tianjin Union Medical Center

30119030@nankai.edu.cn+86 13072272222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026